Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × stenoparib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Carboplatin 19 durvalumab 18 Etoposide 18 atezolizumab 17 PM 01183 10 Topotecan 8 pembrolizumab 6 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Drug Therapy 5 Paclitaxel 4 Bevacizumab 4 AMG 757 4 anlotinib 3 amrubicin 3 Temozolomide 3 Radiotherapy 3 Platinum 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 tremelimumab 2 toripalimab 2 sacituzumab govitecan 2 olaparib 2 monalizumab 2 enzalutamide 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06681220 2026-03-11

Relapsed SCLC

VA Office of Research and Development

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡